author-photo

Joyce O'Shaughnessy

Texas Oncology
Baylor University Medical Center
Baylor University

494

Papers

32854

Citations

Citation Trend

Filter By

Papers (494) Sort By

JournalConferenceOthers

Abstract P1-15-05: Identifying educational needs and areas for improvement in the management of HR+, HER2- breast cancer using cyclin-dependent kinase 4/6 inhibitors

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT2-02-02: MONARCH E: A phase 3 study of standard adjuvant endocrine therapy with or without abemaciclib in patients with high risk, node positive, hormone-receptor positive, human epidermal growth factor receptor 2-negative early-stage breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Advancing the Field of Breast Cancer Care.

2020 Oncology
- Joyce O'Shaughnessy
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-02-06: Tracing glucose catabolism in human triple negative breast cancer tumors

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT1-07-06: Phase 1/2 first-in-human study of U3-1402, an anti-human epidermal growth factor receptor 3 (HER3) antibody-drug conjugate, in HER3-expressing advanced/unresectable or metastatic breast cancer, including those with triple negative breast cancer (TNBC) or HER3-low disease

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab for Early Triple-Negative Breast Cancer

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (428)
Abstract P2-15-09: Systemic corticosteroid use in patients with metastatic triple-negative breast cancer treated with first-line therapy in the United States

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-10-31: Patterns of protein expression and signaling assessed by reverse phase protein array (RPPA) in estrogen-receptor negative (ER-), HER2-amplified breast cancer (BC) that was primary-refractory to preoperative (preop) HER2-directed therapy

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-01-06: Cell-free DNA (cfDNA) analysis of ESR1-mutant advanced breast cancer (aBC): Impact of subsequent therapy on mutation persistence

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-19-09: Updated subgroup tumor response of abemaciclib plus aromatase inhibitor for hormone receptor positive (HR+), HER2 negative advanced breast cancer (MONARCH 3)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号